2013/2 GaBI Journal Table of Contents


Editor’s Letter

What to look forward to in GaBI Journal, 2013, Issue 2


National and regional activities by sickness funds in Austria to encourage the rational use of medicines

Letters to the Editor

Access to liposomal generic formulations: beyond AmBisome and Doxil/Caelyx

Challenges to generic medicines utilization in Yemeni healthcare system

Original Research

How do regional sickness funds encourage more rational use of medicines, including the increase of generic uptake? A case study from Austria

Review Article

Pharmacokinetics of antimicrobials in obese children


Why bioequivalence and unconditional interchangeability of generic drugs are not the same

Equivalence of generic medicines in general and immunosuppressants in particular – a regulatory opinion on switching of ciclosporin, tacrolimus and mycophenolate mofetil

Biosimilars in oncology: current and future perspectives

Biosimilarity in Latin America


Update on clinical practice guideline on the use of epoetin and darbepoetin in adult patients with cancer

Conference Report

Recent trends and special topics in new drug review in PMDA



Source URL: https://gabi-journal.net/2401.html

Generics and Biosimilars Initiative (GaBI)
Tel: +32 474989572 | Fax: +32 14 583 048